In Vitro Studies on Pharmacological Regulation and Genetic Risk Factors of Peripheral Human Nociceptors

NCT00223366 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2007

Last updated 2020-11-03

No results posted yet for this study

Summary

This protocol is for a number of in vitro studies using human surgical biopsies and evaluating the pharmacology and genetics of human nociceptors ("pain detecting") neurons

Conditions

Sponsors & Collaborators

  • National Institutes of Health (NIH)

    collaborator NIH
  • National Institute of Neurological Disorders and Stroke (NINDS)

    collaborator NIH
  • The University of Texas Health Science Center at San Antonio

    lead OTHER

Principal Investigators

  • Kenneth M. Hargreaves, DDS, PhD · University of Texas Health Science Center at San Antonio, Texas

Eligibility

Min Age
16 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2001-10-31
Primary Completion
2019-05-19
Completion
2019-05-19

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00223366 on ClinicalTrials.gov